Long-term survival in adult acute lymphoblastic leukemia: follow-up of a Southeastern Cancer Study Group trial.
- 1 August 1985
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 3 (8), 1053-1058
- https://doi.org/10.1200/jco.1985.3.8.1053
Abstract
Current observation was obtained for adults treated on a protocol for acute lymphoblastic leukemia, which was open from 1972 to 1978, in order to determine the long-term outcome and to evaluate potential prognostic factors. Long-term survival (five + years) was seen in 32% (25/79) of patients who achieved complete remission; 16/79 remain in first remission and 2/79 are currently in second remission. Young age (less than 40) and female sex were significant prognostic factors for long-term survival, but the basis for this advantage is unclear. Further improvements in chemotherapy are needed.This publication has 7 references indexed in Scilit:
- Long-term survival in adolescent and adult acute lymphoblastic leukemiaCancer, 2006
- Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patientsEuropean Journal of Cancer and Clinical Oncology, 1982
- ADOLESCENT AND ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - PROGNOSTIC FEATURES AND OUTCOME OF THERAPY - A STUDY OF 293 PATIENTS1982
- Natural history of central nervous system acute leukemia in adultsCancer, 1981
- COMBINATION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA WITH RANDOMIZED CENTRAL NERVOUS-SYSTEM PROPHYLAXIS1980
- PROGNOSTIC INFLUENCE OF PRETREATMENT CHARACTERISTICS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA1980
- Adult acute leukemia.Frequency of central nervous system involvement in long term survivorsCancer, 1977